Cetera Advisors LLC West Pharmaceutical Services Inc Transaction History

Cetera Advisors LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$338.27 - $413.0 $344,697 - $420,847	1,019 Added 87.09%	2,189 $866,000
Q4 2023 Feb 13, 2024	BUY	$318.29 - $392.21 $23,871 - $29,415	75 Added 6.85%	1,170 $411,000
Q3 2023 Nov 14, 2023	SELL	$354.9 - $412.41 $9,227 - $10,722	-26 Reduced 2.32%	1,095 $410,000
Q2 2023 Aug 09, 2023	SELL	$334.63 - $382.47 $6,692 - $7,649	-20 Reduced 1.75%	1,121 $428,000
Q1 2023 May 15, 2023	BUY	$232.5 - $346.47 $38,827 - $57,860	167 Added 17.15%	1,141 $395,000
Q4 2022 Feb 14, 2023	BUY	$209.34 - $261.61 $203,897 - $254,808	974 New	974 $229,000
Q1 2021 May 17, 2021	SELL	$257.29 - $307.53 $246,998 - $295,228	-960 Closed	0 $0
Q4 2020 Feb 17, 2021	SELL	$261.16 - $301.66 $26,116 - $30,166	-100 Reduced 9.43%	960 $272,000
Q3 2020 Nov 13, 2020	SELL	$224.99 - $288.02 $53,997 - $69,124	-240 Reduced 18.46%	1,060 $291,000
Q2 2020 Aug 13, 2020	BUY	$149.8 - $227.17 $194,740 - $295,321	1,300 New	1,300 $295,000

803

64.4M

294K

490K

Ticker WST
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 74,033,000
Market Cap $24.7B
Description
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...

Get notified when there are updates to the investment portfolio of Cetera Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Cetera Advisors LLC with notifications on news.